Related Experiment Video
Updated: Aug 7, 2026
09:00
A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions
Published on: April 18, 2025
[Proteome analysis--basis for individualized pancreatic carcinoma therapy?]
J M Löhr1, R Faissner, P Findeisen
1Klinische Kooperationseinheit für Molekulare Gastroenterologie (dkfz E180), II. Medizinische Klinik, Medizinische Fakultät Mannheim der Universität Heidelberg. matthias.loehr@med.ma.uni-heidelberg.de
Der Internist
|June 15, 2006
Summary
Pancreatic cancer proteomics offers new hope for identifying diagnostic and prognostic markers. This technology may lead to a better understanding of pancreatic cancer
Area of Science:
- Proteomics
- Molecular biology
- Biomarker discovery
Context:
- Pancreatic ductal adenocarcinoma has a poor prognosis.
- Genomic and transcriptomic data have not yielded clinical biomarkers.
- Proteomics offers a novel approach to understanding pancreatic cancer.
Purpose:
- To review the current state of pancreatic cancer proteomics.
- To discuss technical developments in the field.
- To explore the potential of proteomics for clinical applications.
Summary:
- Proteomics can incorporate posttranslational modifications and host factors, crucial for understanding chemoresistance and survival.
- Current proteomic applications in pancreatic cancer are nascent.
- Early results show promise for identifying specific disease markers and enabling personalized therapy.
Impact:
- Potential for improved diagnostics and prognostics in pancreatic cancer.
- Advancement of molecular understanding of pancreatic cancer.
- Foundation for rational, individualized pancreatic cancer treatment strategies.
